NVST (NVST)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 1.7.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency for NVST presents a significant concern, characterized by an ROIC of 3.5% that falls substantially below the estimated WACC of 8.9%, resulting in a negative spread of -5.4%. This indicates the firm is currently destroying shareholder value through its core operations rather than generating excess returns. Despite this fundamental weakness, the DuPont components reveal a nuanced picture where robust gross margins at 54.7% and moderate revenue growth of 8.3% are offset by critically thin net margins of just 1.7%. While the Piotroski F-Score of 6/9 suggests reasonable financial strength relative to peers, an Altman Z-Score of 1.7 places the company in a zone indicating potential distress or high bankruptcy risk, creating a stark contrast with its relatively clean Beneish M-Score of -2.51 which typically signals low earnings manipulation probability.
Valuation metrics reflect extreme market optimism that appears entirely disconnected from the underlying capital efficiency dynamics. The current P/E ratio of 87.7x sits at a premium multiple, suggesting investors are pricing in aggressive future growth and margin expansion that has not yet materialized in the bottom line. This disparity is highlighted by the DCF fair value estimate of $54, which implies a necessary re-rating to justify the existing share price given the current return profile. Essentially, the market valuation assumes a fundamental transformation in operating leverage or cost structure that contradicts the current reality where returns on invested capital remain negative relative to the cost of equity.
The risk-reward landscape is skewed heavily toward downside volatility due to the combination of value-destructive operations and elevated distress indicators. The proximity of the Altman Z-Score to bankruptcy territory introduces significant tail risks, while the massive gap between the current P/E and implied fair value suggests a high probability of multiple compression if growth expectations are not met immediately. Although the low Beneish score offers some comfort regarding earnings integrity, it does not mitigate the operational inefficiencies evident in the negative ROIC spread or the precarious solvency metrics inherent to an Altman Z-Score below 2.0.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6.9% | 8.9% | 10.9% |
|---|---|---|---|
| 2% | $69 | $47 | $36 |
| 3% | $85 | $54 | $39 |
| 4% | $112 | $64 | $44 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.9%, terminal growth 3%. Fair value $54 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XHE or MDYV, the fund manager is mechanically forced to buy or sell NVST shares regardless of NVST's individual fundamentals. We estimate $130M of passive capital is structurally linked to NVST through 8 tracked ETFs. Passive flows have a limited but growing influence on NVST's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in NVST to visualize passive redemption contagion across ETFs and collateral stocks.
If NVST (NVST) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies STAAR SURGICAL CO (STAA) as the most exposed collateral stock, sharing 1 ETFs with NVST. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
NVST Ownership Dynamics
ETFs with Highest NVST Exposure
Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
NVST Capital Efficiency
How efficiently does NVST convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
NVST converts 63% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-5.4%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-05 | 262 | $25.81 | $6,762.22 |
| 2026-04-10 | 5,816 | $26.67 | $155,112.72 |
| 2026-03-03 | 20,966 | $29.44 | $617,239.04 |
| 2026-02-11 | 597 | $30.17 | $18,011.49 |
| 2026-01-29 | 449 | $24.08 | $10,811.92 |
| 2026-01-16 | 1,177 | $24.69 | $29,060.13 |
| 2026-01-08 | 10 | $22.93 | $229.3 |
| 2026-01-07 | 20,943 | $23.21 | $486,087.03 |
| 2025-12-29 | 988 | $21.99 | $21,726.12 |
| 2025-12-22 | 7,481 | $22.28 | $166,676.68 |
| 2025-12-16 | 5 | $22.06 | $110.3 |
| 2025-12-02 | 108 | $20.77 | $2,243.16 |
| 2025-11-12 | 347,000 | $20.21 | $7.0M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare NVST to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.